Cargando…

Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice

BACKGROUND: Stroke is a major cause of morbidity and mortality. Stroke is complicated by brain edema and blood-brain barrier (BBB) disruption, and is often accompanied by increased release of arginine-vasopressin (AVP). AVP acts through V1a and V2 receptors to trigger hyponatremia, vasospasm, and pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeynalov, Emil, Jones, Susan M., Seo, Jeong-Woo, Snell, Lawrence D., Elliott, J. Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537303/ https://www.ncbi.nlm.nih.gov/pubmed/26275173 http://dx.doi.org/10.1371/journal.pone.0136121

Ejemplares similares

Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke
por: Zeynalov, Emil, et al.
Publicado: (2016)

Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice
por: Zeynalov, Emil, et al.
Publicado: (2017)

Development and validation of an HPLC–MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study
por: Alrabiah, Haitham, et al.
Publicado: (2018)

Arginine Vasopressin, Synaptic Plasticity, and Brain Networks
por: Marcinkowska, Anna B., et al.
Publicado: (2022)

Blockade of Arginine Vasopressin receptors prevents blood-brain barrier breakdown in Experimental Autoimmune Encephalomyelitis
por: Viñuela-Berni, Verónica, et al.
Publicado: (2020)

Conivaptan and its role in the treatment of hyponatremia
por: Ghali, Jalal K, et al.
Publicado: (2009)

The Effect of Intravenous Conivaptan on Intraocular Pressure
por: Krishnankutty, Saritha Valsala, et al.
Publicado: (2016)

The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review
por: Chojnowski, Karol, et al.
Publicado: (2023)

Lycium barbarum Extracts Protect the Brain from Blood-Brain Barrier Disruption and Cerebral Edema in Experimental Stroke
por: Yang, Di, et al.
Publicado: (2012)

Conivaptan: a step forward in the treatment of hyponatremia?
por: Hline, Su Su, et al.
Publicado: (2008)

Transcellular blood–brain barrier disruption in malaria-induced reversible brain edema
por: Jin, Jessica, et al.
Publicado: (2022)

Conivaptan: Evidence supporting its therapeutic use in hyponatremia
por: Li-Ng, Melissa, et al.
Publicado: (2010)

Pharmacokinetics of conivaptan use in patients with severe hepatic impairment
por: Marbury, Thomas, et al.
Publicado: (2017)

Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016)

Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury
por: Randesi, Matthew, et al.
Publicado: (2017)

Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature
por: Hedna, Vishnumurthy Shushrutha, et al.
Publicado: (2014)

Sex Differences in the Regulation of Offensive Aggression and Dominance by Arginine-Vasopressin
por: Terranova, Joseph I., et al.
Publicado: (2017)

A Volumetric and Functional Connectivity MRI Study of Brain Arginine-Vasopressin Pathways in Autistic Children
por: Shou, Xiao-Jing, et al.
Publicado: (2017)

Severe Blood–Brain Barrier Disruption in Cardioembolic Stroke
por: Liu, Chang, et al.
Publicado: (2018)

Effects of arginine vasopressin on musical working memory
por: Granot, Roni Y., et al.
Publicado: (2013)

Oxytocin and arginine vasopressin systems in the domestication process
por: Fam, Bibiana S.O., et al.
Publicado: (2018)

Effects of arginine vasopressin on the urine proteome in rats
por: An, Manxia, et al.
Publicado: (2017)

Arginine vasopressin: Direct and indirect action on metabolism
por: Yoshimura, Mitsuhiro, et al.
Publicado: (2021)

Antagonists of the Vasopressin V1 Receptor and of the β(1)-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes – but the Mechanisms Differ
por: Hertz, Leif, et al.
Publicado: (2014)

Therapeutic Potential of a Vasopressin V2 Receptor Antagonist for Calcium Channel Blocker-Associated Edema with Vasospastic Angina
por: Toda, Kojiro, et al.
Publicado: (2022)

Characterization of the Blood Brain Barrier Disruption in the Photothrombotic Stroke Model
por: Weber, Rebecca Z., et al.
Publicado: (2020)

Cerebral Edema Formation After Stroke: Emphasis on Blood–Brain Barrier and the Lymphatic Drainage System of the Brain
por: Chen, Sichao, et al.
Publicado: (2021)

Arginine Vasopressin and Arginine Vasopressin Receptor 1b Involved in Electroacupuncture‐Attenuated Hypothalamic‐Pituitary‐Adrenal Axis Hyperactivity in Hepatectomy Rats
por: Zhu, Jing, et al.
Publicado: (2015)

Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain
por: Gonzalez, Ana M, et al.
Publicado: (2010)

Brain Edema After Ischaemic Stroke
por: Dostovic, Zikrija, et al.
Publicado: (2016)

Arginine vasopressin in the medial amygdala causes greater post-stress recruitment of hypothalamic vasopressin neurons
por: Tong, Wen Han, et al.
Publicado: (2021)

Arginine vasopressin--a mediator of chemotherapy induced emesis?
por: Edwards, C. M., et al.
Publicado: (1989)

Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009)

Effect of bladder distension on arginine vasopressin secretion in rats
por: Morizawa, Yosuke, et al.
Publicado: (2019)

Altered offspring neurodevelopment in an arginine vasopressin preeclampsia model
por: Gumusoglu, Serena Banu, et al.
Publicado: (2021)

Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

The Application of MRI for Depiction of Subtle Blood Brain Barrier Disruption in Stroke
por: Israeli, David, et al.
Publicado: (2010)

Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Role of NADPH Oxidases in Blood–Brain Barrier Disruption and Ischemic Stroke
por: Hernandes, Marina S., et al.
Publicado: (2022)

Dose comparison of conivaptan (Vaprisol(®)) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics
por: Palmer, Biff F, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dgmdnhvp3925hq5oskblebk3rf